Treatment of restriction in fetal growth with L-arginine: randomized clinical trial, double-blind, controlled with placebo

Fundación para Formación e Investigación Sanitaria0 个研究点目标入组 130 人开始时间: 2018年3月12日最近更新: 2019年1月14日

适应症

试验速览

暂无简介。

•1. Age =18 years
•2. Single pregnancy
•3. Ultrasonographic diagnosis of IUGR: estimated fetal weight lower than the 10th percentile for gestational age according to local or national reference values, independently of the results of the Doppler parameters of the umbilical, middle cerebral and/or uterine arteries
•4. Live fetuses at 11 and 13 at weeks gestation
•6. Gestational age between 24 and 32 weeks
•7. No indication of imminent or planned birth
•8. Availability to participate in the study and sign the consent

•1. Women with medical complications such as preeclampsia, chronic hypertension, kidney disease, diabetes mellitus, liver dysfunction, autoimmune disease or other significant medical complications
•2. Women with a history of major mental disorders (schizophrenia, manic-depressive illness)
•3. Women in labor or with imminent or planned delivery
•4. Fetal malformation
•5. Acute fetal distress
•6. IUGR associated with infectious disease
•7. Multiple pregnancy

发起方

Fundación para Formación e Investigación Sanitaria